The latest decision of Israel’s authorities to reopen the country has shocked the world. However, some governments are admiring this decision and start following this example.
The country spent almost $40 million on 2.4 million antibody tests purchase. The tests were bought from two manufacturers that were previously given the emergency use authorization by the FDA. To make it worse, not all the FDA approved antibody tests are reliable enough for country reopening.
Nevertheless, they are planning on going back to normal as soon as serology testing is done in a week or two, Nearly 100,000 people will get tested for COVID-19 antibodies, which makes Israel one of the most advanced countries in fighting the novel virus.
Whether their plan to detect herd immunity to coronavirus is going to succeed or they are just going to cause a second wave of infections is uncertain.
Moshe Bar-Siman-Tov, director-general of Israel’s health ministry, is quite optimistic about the antibody testing. According to him: “Luckily, the Covid-19 caught us post-influenza season. But we can’t assume that there’s not going to be a next wave or that it will be during summertime.”
After the testing, the officials will decide whether schools and businesses are going to reopen fully. Since Monday, the government ended the 40-day lockdown, and people are out on the streets again, but big companies are still shut.
Death cases per million of the population in Israel are 27, while in the U.S., 213.